Teleflex enrolls first patient in MANTA Vascular Closure Device registry

Teleflex announced the first patient enrollment in a clinical registry that is intended to examine and collect data on outcomes of contemporary on-label use of the MANTA Vascular Closure Device – VCD – in standard of care transcatheter aortic valve replacement – TAVR – procedures. The registry will include appropriate patient selection and proper vascular access. The ACCESS-MANTA Registry is an international, multicenter, prospective, observational, single-arm clinical registry. It will employ the primary objectives of safety and effectiveness.